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Abstract
Background: There are many reports about the anti-arrhythmic effects of ω-3 polyunsaturated fatty acids, however, 
the mechanisms are still not completely delineated. The purpose of this study was to investigate the characteristics of 
action potentials and transient outward potassium currents (Ito) of Sprague-Dawley rat ventricular myocytes and the 
effects of docosahexaenoic acid (DHA) on action potentials and Ito.
Methods: The calcium-tolerant rat ventricular myocytes were isolated by enzyme digestion. Action potentials and Ito of 
epicardial, mid-cardial and endocardial ventricular myocytes were recorded by whole-cell patch clamp technique.
Results: 1. Action potential durations (APDs) were prolonged from epicardial to endocardial ventricular myocytes (P < 
0.05). 2. Ito current densities were decreased from epicardial to endocardial ventricular myocytes, which were 59.50 ± 
15.99 pA/pF, 29.15 ± 5.53 pA/pF, and 12.29 ± 3.62 pA/pF, respectively at +70 mV test potential (P < 0.05). 3. APDs were 
gradually prolonged with the increase of DHA concentrations from 1 μmol/L to 100 μmol/L, however, APDs changes 
were not significant as DHA concentrations were in the range of 0 μmol/L to 1 μmol/L. 4. Ito currents were gradually 
reduced with the increase of DHA concentrations from 1 μmol/L to 100 μmol/L, and its half-inhibited concentration 
was 5.3 μmol/L. The results showed that there were regional differences in the distribution of action potentials and Ito in 
rat epicardial, mid-cardial and endocardial ventricular myocytes. APDs were prolonged and Ito current densities were 
gradually reduced with the increase of DHA concentrations.
Conclusion: The anti-arrhythmia mechanisms of DHA are complex, however, the effects of DHA on action potentials 
and Ito may be one of the important causes.
Background
Fatty acids, especially polyunsaturated fatty acids
(PUFAs), play an important role in life and death of car-
diac cells. Reasons are as follow: 1. they are essential fuels
for mechanical, electrical, and synthetic activities of the
heart; 2. their levels are abnormally high in an ischemia
followed by a reperfusion; and 3. dietary fish oil is appar-
ently beneficial for heart function [1,2]. Therefore, the
beneficial effects of PUFAs on cardiovascular diseases,
such as fish oil, have been reported, and the effects of
PUFAs on anti-arrhythmias and prevention of sudden
death have been highlights [3-6]. It has been reported
that PUFAs have the roles of anti-arrhythmias and pre-
vention of malignant ventricular arrhythmias, however,
the mechanisms of which are still not completely delin-
eated [7,8].
ω-3 PUFAs mainly include docosahexaenoic acid
(DHA) and eicosapentaenoic acid (EPA). More attentions
have been paid to their beneficial effects on cardiovascu-
lar diseases in recent years, especially in their anti-
arrhythmias and prevention of sudden cardiac death [9-
13]. However, most of these studies are clinical trials, and
the mechanisms of which are still not completely known.
To investigate the mechanisms of ω-3 PUFAs on anti-
* Correspondence: ruxingw@sina.com.cn
1 Department of Cardiology, Affiliated Hospital of Nanjing Medical University in 
Wuxi and People's Hospital of Wuxi City, Wuxi 214023, China
Full list of author information is available at the end of the articleWang et al. Lipids in Health and Disease 2010, 9:39
http://www.lipidworld.com/content/9/1/39
Page 2 of 7
arrhythmias and prevention of sudden cardiac death
[1,8], we observed the effects of DHA on action poten-
tials and transient outward potassium currents (Ito) of
Sprague-Dawley rat ventricular myocytes by whole-cell
patch clamp technique in this study. The results may pro-
vide some experimental evidences for rational applica-
tions of ω-3 PUFAs to prevent and treat arrhythmias in
clinical practice.
Methods
Major experimental instruments
The instruments used were: MultiClamp 700B patch
clamp amplifier (Axon Instruments, USA), D/A and A/D
converter (DigiData 1322, Axon Instruments, USA),
Pclamp 9.0 pulse software (Axon Instruments, USA),
MP-285 motorized micromanipulator (Sutter Instru-
ments, USA), IX71 inverted microscope (Olympus,
Japan), SA-OLY/2 and DH-35 culture dish heater (War-
ner Instruments, USA), P-97 micropipette puller (Sutter
Instruments, USA).
Reagents, solutions and drugs
The reagents, solutions and drugs used were: DHA
(Sigma, USA), molecular weight 328.5, 100 mmol/L stock
solution was prepared by being dissolved in absolute eth-
anol and protected from light in refrigerator at -20°C. The
experimental concentration of DHA was obtained by
dilution of stock solution before each experiment. Action
potential internal solution (in mmol/L) was KCl 120,
CaCl2 1, MgCl2 5, Na2 ATP 5, EGTA 11, HEPES 10, glu-
cose 11, pH 7.3 adjusted with KOH. Action potential
external solution was Tyrode's solution [14]. Ito external
solution (in mmol/L) was NaCl 140, KCl 4, CaCl2 1.5,
MgCl2 1, CdCl2 0.5, HEPES 5, glucose 10, pH 7.4 adjusted
with NaOH. Ito internal solution (in mmol/L) was KCl
140, MgCl2 1, K2 ATP 5, EGTA 5, HEPES 10, pH 7.4
adjusted with KOH. KB solution (in mmol/L) was L-Glu-
tamic acid 50, KCl 40, KH2PO4 20, Taurine 20, MgCl2 3,
KOH 70, EGTA 0.5, HEPES 10, glucose 10, pH 7.4
adjusted with KOH.
Cell isolation
The investigation was approved by our institute ethics
committee and conformed to the Guide for the Care and
Use of Laboratory Animals published by the US National
Institutes of Health (NIH publication No. 85-23, revised
1996). Healthy Sprague-Dawley rats of either sex, aged 8-
12 weeks and weighing approximately 200 g, were pro-
vided b y t he  Ex perim e n ta l Anim a l C e n t e r of  Sooc how
University (Suzhou, China). Animals were anesthetized
with pentobarbital sodium intraperitoneally (i.p.), Hearts
were removed and retrograde perfusion through the
aorta was performed as described [15]. After retrograde
perfusion was finished, epicardial, mid-cardial, and endo-
cardial ventricular myocardium were obtained respec-
tively by cutting with eye scissor and plyer. Isolated cells
were kept at room temperature in KB solution and used
within 6 hr; only relaxed, striated, and rod-shaped cells
were used.
Recordings of action potentials and Ito with and without 
DHA
Currents in whole-cell voltage clamp configuration were
recorded following the method of Hamill et al [16]. Myo-
cytes were transferred to a 1 ml chamber (DH-35 culture
dish heater, Warner Instruments, USA) containing exter-
nal solution placed on the stage of an inverted micro-
scope. The chamber was continuously perfused at a rate
of 1-2 ml/min with external solution. Electrodes were
prepared from borosilicate glass (Clark Instruments, UK)
using P-97 micropipette puller with resistances typically
between 2 and 4 MΩ when filled with internal solution.
Whole-cell voltage-clamp experiments were performed
with MultiClamp 700B amplifier. Whole-cell capacitance
and series resistance were compensated by 60-80%.
Experiments were performed at 36-37°C. Voltage clamp
pulses were generated via an IBM-compatible computer
connected to Digidata 1322. Data acquisition and analy-
ses were performed using pCLAMP software. To obtain
action potentials, 5 ms depolarizing pulse with 900pA, 1
Hz in current-clamp configuration was applied. DHA at
0.01 μmol/L, 0.1 μmol/L, 1 μmol/L, 10 μmol/L, and 100
μmol/L was perfused for 10 min respectively to observe
the influence on action potential durations (APDs). To
obtain Ito, 600 ms depolarizing pulses in the range -40 mV
to +70 mV were applied to the ventricular myocytes every
5 s in +10 mV increment from -40 mV holding potential
(HP). Recordings of action potentials and Ito were per-
formed at physiological temperature range (36-37°C).
DHA at various concentrations was applied to investigate
the effects on Ito.
Statistical analysis
Continuous variables were expressed as mean ± standard
error (  ± se). SPSS11.5 (SPSS Inc, Chicago, Illinois,
USA) was used for statistical analysis. Comparisons
among groups were performed by repeated measurement
analysis of variance (ANOVA) and least-significant differ-
ence contrast. Control and drug data for individual
groups were compared by Paired t-test. P ≤ 0.05 was con-
sidered significant. OriginPro 7.5 software (OriginLab,
USA) was utilized to calculate the half-inhibited concen-
tration (IC50).
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Results
Characteristics of action potentials and Ito of rat ventricular 
myocytes
Action potentials of epicardial, mid-cardial and endocar-
dial ventricular myocytes were recorded respectively with
action potential stimulus protocol. The action potential
morphologies were different in epicardial, mid-cardial
and endocardial ventricular myocytes (Figure 1). APD25,
APD50, and APD90 were gradually prolonged from epicar-
dial to endocardial ventricular myocytes. Table 1 showed
APDs' variations in myocytes of different layers; however,
maximal velocity of action potential depolarization
(Vmax), amplitude (APA), and overshoot (OS), didn't
have remarkable changes in epicardial, mid-cardial and
endocardial ventricular myocytes (Table 2).
Ito current tracings at various test potentials were elic-
ited by 600 ms depolarization in the range of -40 mV to
+70 mV pulses applied to the ventricular myocytes every
5 s in +10 mV increments from -40 mV HP. The represen-
tative current tracings were shown in figure 2. The cur-
rent densities of epicardial, mid-cardial and endocardial
ventricular myocytes at +70 mV were 59.50 ± 15.99 pA/
pF, 29.15 ± 5.53 pA/pF, and 12.29 ± 3.62 pA/pF, respec-
tively.
The current-voltage curves of Ito were plotted with cur-
rent densities at each test potential (Figure 3). The
threshold potential of Ito channel opening was -30.3 ± 2.8
mV, i.e., Ito channel began to activate at more than -30 mV.
Ito currents were gradually enhanced with the increase of
test potentials. The activation of Ito channel was very
rapid, and only needed to about 10 ms, nonetheless, its
inactivation was relatively slow. The time constants of
epicardial, mid-cardial, and endocardial ventricular myo-
cytes were almost the same at each test potential. They
were 31.8 ± 1.7 ms, 32.9 ± 2.4 ms, and 33.2 ± 2.9 ms,
respectively, at +70 mV test potential (P > 0.05).
Effects of DHA on action potentials
DHA at 0.01 μmol/L, 0.1 μmol/L, 1 μmol/L, 10 μmol/L,
and 100 μmol/L was applied on epicardial ventricular
myocytes, respectively. The results showed that: Ђ APDs
were gradually prolonged with the increase of DHA,
whereas APDs' changes were not significant at low con-
centration of DHA (<1 μmol/L). The prolongation of
APD25, APD50, and APD90 was less than 15% compared
with the control (0 min) when 0.1 μmol/L DHA was
applied (Figure 4). ? APDs were prolonged in a concentra-
tion-dependent manner when DHA concentrations were
more than 1 μmol/L. APD25, APD50, and APD90 were 7.7
± 2.0 ms, 21.2 ± 3.5 ms, and 100.1 ± 9.8 ms respectively
when 10 μmol/L DHA was used at 5 min (Figure 5C).
APD25, APD50, and APD90 were 15.2 ± 4.0 ms, 45.7 ± 6.8
ms, and 215.6 ± 15.7 ms respectively when 100 μmol/L
DHA was utilized at 5 min (Figure 5D), which was signif-
icantly prolonged compared with those without addition
of DHA (P < 0.05).
Effects of DHA on Ito
DHA at 0.01 μmol/L, 0.1 μmol/L, 1 μmol/L, 10 μmol/L,
and 100 μmol/L was applied, respectively. Ito currents
were blocked by DHA in a concentration-dependent
manner. Currents were gradually decreased with the
increase of DHA concentrations. The current density of
Ito at +70 mV was 30.1 ± 7.2 pA/pF with DHA at 100
μmol/L. The representative current tracings blocked by
DHA at 100 μmol/L were shown in figures 6. IC50 of DHA
on Ito w a s  f i t t e d  w i t h  H i l l  f u n c t i o n  a n d  c a l c u l a t e d  b y
OriginPro 7.5 software, which was 5.3 μmol/L.
Discussion
The typical action potential consists of 5 phases or stages,
i.e., 0, 1, 2, 3, and 4. The present study has showed that
the rat ventricular myocytes don't have the typical action
potential morphology. APDs are the shortest in epicardial
ventricular myocytes, and repolarization rapidly appears
after depolarization, showing no platform phase [17]. The
phenomenon of "spike and dome" [18] sometimes can be
seen, however, this phenomenon does not appear in
endocardial ventricular myocytes. Action potential repo-
larization in endocardial ventricular myocytes is slow,
showing relative standard action potential morphology.
The action potential morphologies of mid-cardial ven-
tricular myocytes are between epicardial and endocardial
ventricular myocytes [19,20], but action potential repo-
larization is still rapid, and has the tendency of platform
phase compared with the epicardial ventricular myo-
cytes. The reasons why these alterations appear are that
there are regional differences of Ito in epicardial, mid-car-
dial and endocardial ventricular myocytes. The Ito chan-
nels are the most abundant in rat epicardial ventricular
Figure 1 Action potential morphologies of rat ventricular myo-
cytes: A, B and C were action potentials in epicardial, mid-cardial and 
endocardial ventricular myocytes, respectively. Action potential dura-
tions were gradually increased from epicardial ventricular myocytes to 
endocardial ventricular myocytes.Wang et al. Lipids in Health and Disease 2010, 9:39
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myocytes and then in mid-cardial and endocardial ven-
tricular myocytes by turns. The Ito current densities in
epicardial, mid-cardial and endocardial ventricular myo-
cytes were different in this study, which further illustrates
that Ito channels of rat ventricular myocytes have regional
differences. Ito  channels in epicardial myocytes are
extremely abundant, and therefore, Ito currents are the
largest, which makes action potential repolarization
rapid, calcium inflow time and APDs short. In contrast,
Ito channels in endocardial myocytes are few or lack, and
therefore, APDs prolong. APA, Vmax, and OS are formed
mainly by 0 phase depolarization. Because regional dif-
ferences of Ito channels do not affect depolarization of
ventricular myocytes, and thus, APA, Vmax, and OS
don't have significant differences in epicardial, mid-car-
dial and endocardial myocytes [21].
The Ca2+-insensitive but 4-aminopyridine-sensitive Ito
currents play a major role in modulating cardiac electri-
cal activity [22]. It underlies phase 1 repolarization, and
thus, by setting the voltage of the early plateau phase, it
influences activation and inactivation of other plateau
currents that control repolarization. It has also been
reported in several studies that Ito channels are poten-
tially important targets for both neuromodulatory con-
trol [23] and antiarrhythmic drug actions [24]. These
currents have been suggested to contribute significantly
to the regional electrophysiological heterogeneity within
the ventricular wall, a fact considered to be responsible
for T-wave polarity. The heterogeneous distribution of Ito
thus appears to be essential in causing the transmural
electrical gradients necessary for proper repolarization of
cardiac action potentials. It is expected that changes in Ito
distribution and availability can be expressed in the ECG
by typical J-wave and T-wave alterations and may lead to
cardiac arrhythmias during evolving heart diseases.
The present study results have showed that there are
regional differences of action potentials and Ito amplitude
and morphology of rat epicardial, mid-cardial and endo-
cardial myocytes. Regional differences of action poten-
tials and Ito should be considered when rats are chosen as
the experimental animal. We should try to obtain same
regional ventricular myocytes to avoid experiment errors
when we perform cellular electrophysiological study.
Consequently, in this study, we only chose epicardial
myocytes to investigate the effects of DHA on action
potentials and Ito.
ω-3 PUFAs mainly include DHA and EPA. In order to
investigate the mechanisms of ω-3 PUFAs on anti-
arrhythmias and prevention of sudden death, we per-
formed this experiment to study the effects of DHA on
action potential and Ito of rat ventricular myocytes. The
reasons that we chose the rats as experimental animal is
not only because the rats have many advantages, e.g.
cheap, strong vitality, and easily bred, but more impor-
Table 1: APD25, APD50, and APD90 of epicardial, mid-cardial and endocardial ventricular myocytes
n APD25 (ms) APD50 (ms) APD90 (ms)
Epi 50 3.6 ± 1.2 10.3 ± 2.1 46.3 ± 4.8
Mid 58 6.4 ± 1.8 14.7 ± 2.4 69.4 ± 8.3
Endo 62 13.8 ± 2.1 45.3 ± 10.2 152.1 ± 33.4
P value P < 0.05 P < 0.05 P < 0.05
Epi, Mid, and Endo represent epicardial, mid-cardial and endocardial ventricular myocytes respectively
Table 2: Vmax, APA, and OS of epicardial, mid-cardial and endocardial ventricular myocytes
n Vmax (V/s) APA (mV) OS (mV)
Epi 71 228.3 ± 14.5 110.7 ± 10.1 31.5 ± 5.4
Mid 63 231.2 ± 13.4 111.9 ± 9.3 32.4 ± 6.3
Endo 70 226.9 ± 12.8 109.8 ± 8.9 30.8 ± 4.8
P value P > 0.05 P > 0.05 > 0.05
Epi, Mid, and Endo represent epicardial, mid-cardial and endocardial ventricular myocytes respectively, and Vmax, APA, and OS represent 
maximal velocity of action potential depolarization, action potential amplitude and overshootWang et al. Lipids in Health and Disease 2010, 9:39
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tant is that there are many similar electrophysiological
characteristics of rat and the human being's cardiomyo-
cytes [25,26].
After DHA at various concentrations was applied,
APDs were gradually prolonged and Ito currents were
decreased by degrees with the increase of DHA concen-
trations. DHA could inhibit Ito currents, prolong APDs,
and extend effective refractory period of myocardial
myocytes [27]. The effects of DHA on action potentials
and Ito may be one of its anti-arrhythmia mechanisms.
Figure 6 clearly showed that DHA could inhibit Ito cur-
rents. However, from the morphologic changes of action
p o t e n t i a l s  i n  f i g u r e  5 ,  w e  f o u n d  t h a t  t h e  m o r p h o l o g i c
changes of action potentials mainly appeared in phase 2
and phase 3 with the increase of DHA concentrations. In
contrast, action potential phase 1 formed mainly by Ito
current efflux didn't have significant changes. This means
DHA may have the effects on other ion currents in addi-
tion to Ito current.
The present study has some limitations, e.g., we only
investigated the effects of DHA on action potentials and
Ito of rat ventricular myocytes. On the other hand, ω-3
PUFAs not only include DHA but also EPA, the electro-
physiological effects of EPA on rat ventricular myocytes,
and DHA on other ion currents such as INa, ICa-L, IK, and
IK1 are still needed to further study. Only we completely
explore the anti-arrhythmia mechanisms of ω-3 PUFAs,
we can apply them correctly in clinical practice to prevent
and treat cardiovascular diseases [28-32].
Conclusion
In summary, the present findings obtained by the patch-
clamp technique have clearly shown that APDs are pro-
longed, and Ito currents are gradually reduced with the
Figure 2 The representative current tracings of transient out-
ward potassium currents at various test potentials: Currents were 
elicited by 600 ms depolarizing in the range of -40 mV to +70 mV puls-
es in +10 mV increments from -40 mV holding potential. The currents 
were enhanced with the increase of test potentials, activated rapidly 
and inactivated slowly.
Figure 3 The current-voltage curves of transient outward potas-
sium currents in epicardial, mid-cardial and endocardial ventric-
ular myocytes: Currents in epicardial, mid-cardial and endocardial 
ventricular myocytes were all enhanced with the increase of test po-
tentials from -40 mV to +70 mV, whereas currents in epicardial were 
higher than those in mid-cardial and endocardial at the same test po-
tential, and currents in mid-cardial were larger than those in endocar-
dial.
Figure 4 Action potential changes of rat ventricular myocytes at 
0.1 μmol/L DHA: A, B, and C were morphologies of action potential 
when 0.1 μmol/L DHA was applied at 0 min, 1 min, and 5 min, respec-
tively. The action potential duration was increased; however, com-
pared with the control (0 min), the prolongation of action potential 
duration was less than 15%.
Figure 5 Action potential changes of rat ventricular myocytes at 
different DHA concentrations: A, B, and C were the applications of 10 
μmol/L DHA at 0 min, 1 min, and 5 min. D was DHA at concentration 
of 100 μmol/L for 5 min. Action potential durations were significantly 
prolonged in concentration-dependent manner when DHA concen-
trations were more than 10 μmol/L.Wang et al. Lipids in Health and Disease 2010, 9:39
http://www.lipidworld.com/content/9/1/39
Page 6 of 7
increase of DHA concentrations. Effects of DHA on
action potentials and Ito may be one of the important
causes of anti-arrhythmias.
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